NDC50419-0189-02 — GADOPENTETATE DEMIGLUMINE INJECT

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC50419-0189-02: GADOPENTETATE DEMIGLUMINE INJECT.

GADOPENTETATE DEMIGLUMINE INJECT. Key specifications include primary_container_type: VIAL, SINGLE DOSE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 20, primary_container_content_quantity: 20.000 MILLILITERS, active_medicament_medicinal_strength: 469.010 MILLIGRAMS GADOPENTETATE DIMEGLUMINE PER MILLILITER, part_name_assigned_by_controlling_agency: GADOPENTETATE DEMIGLUMINE INJECTION USP 20ML VIAL 20S. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-310-5873, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC50419-0189-02

NSN: 6505-01-310-5873
FSC: 6505 — Drugs and Biologicals
CAGE: 59463 — BAYER HEALTHCARE PHARMACEUTICALS INC DBA BAYER HEALTHCARE PHARMACEUTICALS INC (USA)

SPECIFICATIONS

special_features	ALSO CONTAINS THE FOLLOWING PER ML: 0.99 MG MEGLUMINE,0.40 MG DIETHYLENETRIAMINE PENTAACETIC ACID AND QS 1 ML STERILE WATER FOR INJECTION; PH OF 6.5 TO 8.0
primary_container_type	VIAL, SINGLE DOSE
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
total_primary_container_quantity	20
primary_container_content_quantity	20.000 MILLILITERS
active_medicament_medicinal_strength	469.010 MILLIGRAMS GADOPENTETATE DIMEGLUMINE PER MILLILITER
part_name_assigned_by_controlling_agency	GADOPENTETATE DEMIGLUMINE INJECTION USP 20ML VIAL 20S
NSN	6505-01-310-5873

COMPONENT DIAGRAM

KEY FEATURES

•

PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 469.010 MILLIGRAMS GADOPENTETATE DIMEGLUMINE PER MILLILITER

•

TOTAL PRIMARY CONTAINER QUANTITY: 20

TECHNICAL CHARACTERISTICS

PRIMARY CONTAINER CONTENT QUANTITY	20.000 MILLILITERS
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	VIAL, SINGLE DOSE
SPECIAL FEATURES	ALSO CONTAINS THE FOLLOWING PER ML: 0.99 MG MEGLUMINE,0.40 MG DIETHYLENETRIAMINE PENTAACETIC ACID AND QS 1 ML STERILE WATER FOR INJECTION; PH OF 6.5 TO 8.0
PART NAME ASSIGNED BY CONTROLLING AGENCY	GADOPENTETATE DEMIGLUMINE INJECTION USP 20ML VIAL 20S
ACTIVE MEDICAMENT MEDICINAL STRENGTH	469.010 MILLIGRAMS GADOPENTETATE DIMEGLUMINE PER MILLILITER
TOTAL PRIMARY CONTAINER QUANTITY	20

SUBSTITUTES & CROSS-REFERENCES 1

MAGNEVISTReference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC50419-0189-02?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC50419-0189-02?

NDC50419-0189-02 is a GADOPENTETATE DEMIGLUMINE INJECT.

What parts can replace NDC50419-0189-02?

There is 1 known substitute for NDC50419-0189-02: MAGNEVIST. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC50419-0189-02?

NDC50419-0189-02 is cataloged in the U.S. Government catalog under NSN 6505-01-310-5873. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC50419-0189-02 — GADOPENTETATE DEMIGLUMINE INJECT

Request a Quote — NDC50419-0189-02